中国医院用药评价与分析2024,Vol.24Issue(8) :995-998.DOI:10.14009/j.issn.1672-2124.2024.08.022

复方苦参注射液治疗放疗所致口腔黏膜炎的有效性的Meta分析

Meta-Analysis on Efficacy of Compound Kushen Injection in the Treatment of Oral Mucositis Induced by Radiotherapy

杨玲
中国医院用药评价与分析2024,Vol.24Issue(8) :995-998.DOI:10.14009/j.issn.1672-2124.2024.08.022

复方苦参注射液治疗放疗所致口腔黏膜炎的有效性的Meta分析

Meta-Analysis on Efficacy of Compound Kushen Injection in the Treatment of Oral Mucositis Induced by Radiotherapy

杨玲1
扫码查看

作者信息

  • 1. 秦皇岛市海港医院肿瘤科,河北秦皇岛 066099
  • 折叠

摘要

目的:评价复方苦参注射液预防与治疗放疗所致口腔黏膜炎的疗效,为该药的临床应用提供循证参考支持.方法:检索中国知网、维普数据库、万方数据库和PubMed,时间为2011年1月1日至2023年7月1日,纳入复方苦参注射液治疗放疗所致口腔黏膜炎的随机对照试验[对照措施为单纯使用放疗,或放疗前使用含漱液(0.9%氯化钠注射液+利多卡因+地塞米松)漱口,或放疗联合顺铂化疗;干预措施为在对照措施基础上联合复方苦参注射液治疗],应用RevMan 5.4统计软件进行Meta分析.结果:经过筛选后纳入10项随机对照试验研究,包含892例患者,根据对照措施分为单纯放疗亚组(356例)、放疗前用含漱液漱口亚组(260例)、放疗联合顺铂化疗亚组(276例).Meta分析结果显示,与单纯放疗、放疗前用含漱液漱口和放疗联合化疗比较,联合应用复方苦参注射液后,患者放射性口腔黏膜炎的严重程度均显著降低.在单纯放疗亚组中,复方苦参注射液组患者的重度放射性口腔黏膜炎发生率为34.27%(61/178),明显低于单纯放疗组的61.24%(109/178),差异有统计学意义(OR=3.49,95%CI=2.19-5.55,Z=5.27,P<0.000 01).在放疗前用含漱液漱口亚组中,复方苦参注射液组患者的重度放射性口腔黏膜炎发生率为18.46%(24/130),明显低于放疗+含漱液组的 58.46%(76/130),差异有统计学意义(OR=6.90,95%CI=2.92-16.30,Z=4.41,P<0.000 1).在放疗联合顺铂化疗亚组中,复方苦参注射液组患者的重度放射性口腔黏膜炎发生率为27.01%(37/137),明显低于放疗+顺铂化疗组的56.12%(78/139),差异有统计学意义(OR=3.68,95%CI=2.18~6.19,Z=4.90,P<0.000 01).结论:对于放疗所致口腔黏膜炎患者,使用复方苦参注射液可以有效减少口腔黏膜炎的发生.

Abstract

OBJECTIVE:To evaluate the efficacy of compound Kushen injection in prevention and treatment of oral mucositis induced by radiotherapy,so as to provide evidence-based reference for the clinical application.METHODS:CNKI,VIP,Wanfang Data and PubMed were retrieved to collect the randomized controlled trial of compound Kushen injection in the treatment oral mucositis induced by radiotherapy[the control measures were radiotherapy alone,or gargling solution(0.9%sodium chloride injection+lidocaine+dexamethasone)before radiotherapy,or radiotherapy combined with cisplatin chemotherapy;the intervention measures were combined with compound Kushen injection on the basis of control measures]from Jan.1st,2011 to Jul.1st,2023.Meta-analysis was performed by using RevMan 5.4 statistical software.RESULTS:After screening,10 randomized controlled trials were enrolled,including 892 patients,who were divided into subgroup of radiotherapy alone(356 cases),subgroup of gargling before radiotherapy(260 cases),and subgroup of radiotherapy combined with cisplatin chemotherapy(276 cases)according to different control measures.Meta-analysis showed that the severity of oral mucositis decreased significantly after combined application of compound Kushen injection compared with radiotherapy alone,gargling before radiotherapy,and radiotherapy combined with chemotherapy.In the subgroup of radiotherapy alone,the incidence of severe radiation-induced oral mucositis in the compound Kushen injection group was 34.27%(61/178),significantly lower than 61.24%(109/178)in the radiotherapy alone group,the difference was statistically significant(OR=3.49,95%CI=2.19-5.55,Z=5.27,P<0.000 01).In the subgroup of gargling before radiotherapy,the incidence of severe radiation-induced oral mucicitis in the compound Kushen injection group was 18.46%(24/130),significantly lower than 58.46%(76/130)in the radiotherapy+gargle group,the difference was statistically significant(OR=6.90,95%CI=2.92-16.30,Z=4.41,P<0.000 1).In the subgroup of radiotherapy combined with cisplatin chemotherapy,the incidence of severe radiation-induced oral mucositis in the compound Kushen injection group was 27.01%(37/137),significantly lower than 56.12%(78/139)in the radiotherapy combined with cisplatin chemotherapy group,the difference was statistically significant(OR=3.68,95%CI=2.18-6.19,Z=4.90,P<0.000 01).CONCLUSIONS:For patients with oral mucositis induced by radiotherapy,compound Kushen injection can effectively reduce the occurrence of oral mucositis.

关键词

复方苦参注射液/放疗/口腔黏膜炎/Meta分析

Key words

Compound Kushen injection/Radiotherapy/Oral mucositis/Meta-analysis

引用本文复制引用

出版年

2024
中国医院用药评价与分析
中国医药生物技术协会,中国药房杂志社

中国医院用药评价与分析

CSTPCD
影响因子:1.142
ISSN:1672-2124
段落导航相关论文